Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis

Starting soon · Phase 4

Conditions studied: Dermatitis, Atopic, Eczema

In brief

This study will compare the efficacy and safety of crisaborole ointment with tacrolimus ointment, in the treatment of patients with mild-to-moderate atopic dermatitis.

Key facts

Study ID

NCT07367932

Run by

Cairo University

People needed

30

Starts

2026-02-01

Expected to finish

2026-07-01

Last updated by the study team

2026-01-26

Who can join

Age: 5 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with diagnosis of AD, according to Hanifin and Rajka criteria.
• Patients of both genders
• Age 5-25 years
• Baseline Investigator's Static Global Assessment (ISGA) score of mild (2) or moderate (3).

You may not qualify if…

• Clinically infected eczema.
• Baseline Investigator's Static Global Assessment (ISGA) score of severe (4).
• Associated comorbidities that exacerbate pruritus.
• Patients receiving topical treatment for AD and/or pruritus within the past 14 days and/or systemic treatment within the past month.
• Pregnancy and lactation if in the childbearing period

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.